Videregen vidregen.com


Videregen offers a commercially available organ replacement product to address the chronic shortage of organs for transplantation. Formed in 2011 as a spin-out from Northwick Park Institute of Medical Research in London, it uses its proprietary technology to produce biological scaffolds to which a patient's own stem cells are added, creating a bespoke organ replacement.

Videregen offers a commercially available organ replacement product to address the chronic shortage of organs for transplantation. Formed in 2011 as a spin-out from Northwick Park Institute of Medical Research in London, it uses its proprietary techn...Show all

Company (Alive / Active)

Phone: +44 (0) 1514 829 350

Fax:

Innovation Centre 1
Liverpool Science Park, 131 Mount Pleasant
Liverpool, L3 5TF
United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Videregen $5M Oct 15, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Videregen Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Implant and method of producing an implant Jun 16, 2014 Application
Implant and method for producing an implant Jul 16, 2013 Application